We are live on ! Find out more
CP

Catalys Pacific Portfolio holdings

AUM $231M
1-Year Est. Return 83.19%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+83.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$311M
AUM Growth
-$40.8M
Cap. Flow
-$36.4M
Cap. Flow %
-11.71%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$3.74M

Top Sells

Rank Stock Value
1
MLYS icon
Mineralys Therapeutics
MLYS
+$40.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLYS icon
1
Mineralys Therapeutics
MLYS
$2.25B
$287M 92.37%
7,903,838
-1,000,000
-11% -$40.1M
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$708M
$23.7M 7.63%
1,429,014
+261,900
+22% +$3.74M

Similar funds

YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
PWA
Prairie Wealth Advisors Omaha, Nebraska $231M AUM 23.67% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
MWM
Massachusetts Wealth Management North Andover, Massachusetts $231M AUM 33.21% 1-Year Est. Return
RF
rebel Financial Groveport, Ohio $231M AUM 12.5% 1-Year Est. Return
ERFOTCOFW
Employees Retirement Fund of the City of Fort Worth Fort Worth, Texas $230M AUM 10.19% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
WF
Wayfinding Financial Lynnwood, Washington $230M AUM 17.64% 1-Year Est. Return

Catalys Pacific's Q4 2025 Portfolio in Review

As of Q4 2025, Catalys Pacific held 2 positions worth $311M, down 12% from $351M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Catalys Pacific withdrew a net $36.4M in Q4 2025, reducing 1 holding. Its largest reduction was Mineralys Therapeutics, cutting an estimated $40.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Catalys Pacific added an estimated $3.74M to Phathom Pharmaceuticals.

  • Catalys Pacific added most to Phathom Pharmaceuticals in Q4 2025, an estimated $3.74M increase.
  • Catalys Pacific's biggest Q4 2025 reduction was Mineralys Therapeutics, cutting an estimated $40.1M.
  • Catalys Pacific's ten largest holdings make up 100% of its $311M portfolio in Q4 2025.
  • Catalys Pacific opened 0 new positions and closed 0 in Q4 2025.
  • Catalys Pacific's portfolio value fell 12% quarter-over-quarter to $311M.

Based on Catalys Pacific's 13F filing for Q4 2025, filed 10 Feb 2026.